188 related articles for article (PubMed ID: 25091591)
1. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.
Panahi Y; Badeli R; Karami GR; Sahebkar A
Phytother Res; 2015 Jan; 29(1):17-21. PubMed ID: 25091591
[TBL] [Abstract][Full Text] [Related]
2. Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial.
Panahi Y; Ghanei M; Hajhashemi A; Sahebkar A
J Diet Suppl; 2016; 13(1):93-105. PubMed ID: 25171552
[TBL] [Abstract][Full Text] [Related]
3. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial.
Panahi Y; Khalili N; Hosseini MS; Abbasinazari M; Sahebkar A
Complement Ther Med; 2014 Oct; 22(5):851-7. PubMed ID: 25440375
[TBL] [Abstract][Full Text] [Related]
4. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial.
Panahi Y; Khalili N; Sahebi E; Namazi S; Simental-Mendía LE; Majeed M; Sahebkar A
Drug Res (Stuttg); 2018 Jul; 68(7):403-409. PubMed ID: 29458218
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder.
Panahi Y; Badeli R; Karami GR; Badeli Z; Sahebkar A
Complement Ther Med; 2015 Aug; 23(4):598-602. PubMed ID: 26275653
[TBL] [Abstract][Full Text] [Related]
6. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Saberi-Karimian M; Keshvari M; Ghayour-Mobarhan M; Salehizadeh L; Rahmani S; Behnam B; Jamialahmadi T; Asgary S; Sahebkar A
Complement Ther Med; 2020 Mar; 49():102322. PubMed ID: 32147075
[TBL] [Abstract][Full Text] [Related]
7. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial.
Panahi Y; Valizadegan G; Ahamdi N; Ganjali S; Majeed M; Sahebkar A
J Cell Biochem; 2019 Sep; 120(9):15989-15996. PubMed ID: 31168845
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.
Panahi Y; Hosseini MS; Khalili N; Naimi E; Majeed M; Sahebkar A
Clin Nutr; 2015 Dec; 34(6):1101-8. PubMed ID: 25618800
[TBL] [Abstract][Full Text] [Related]
9. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
[TBL] [Abstract][Full Text] [Related]
10. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.
Frasure-Smith N; Lespérance F
Arch Gen Psychiatry; 2008 Jan; 65(1):62-71. PubMed ID: 18180430
[TBL] [Abstract][Full Text] [Related]
11. Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice.
Jangra A; Kwatra M; Singh T; Pant R; Kushwah P; Sharma Y; Saroha B; Datusalia AK; Bezbaruah BK
Inflammation; 2016 Jun; 39(3):1025-38. PubMed ID: 26970969
[TBL] [Abstract][Full Text] [Related]
12. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial.
Panahi Y; Alishiri GH; Parvin S; Sahebkar A
J Diet Suppl; 2016; 13(2):209-20. PubMed ID: 25688638
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Activity of Curcumin in Combination with Piperine against Quinolinic Acid Induced Neurodegeneration in Rats.
Singh S; Kumar P
Pharmacology; 2016; 97(3-4):151-60. PubMed ID: 26828892
[TBL] [Abstract][Full Text] [Related]
14. Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication.
Chung KF; Yu YM; Yeung WF
J Affect Disord; 2015 Nov; 186():192-7. PubMed ID: 26247911
[TBL] [Abstract][Full Text] [Related]
15. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study.
Bergman J; Miodownik C; Bersudsky Y; Sokolik S; Lerner PP; Kreinin A; Polakiewicz J; Lerner V
Clin Neuropharmacol; 2013; 36(3):73-7. PubMed ID: 23673908
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
17. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
Jakobsen JC
Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
[TBL] [Abstract][Full Text] [Related]
18. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
